Why the study?
Does brain natriuretic peptide (BNP) level correlate with anthracycline-induced cardiotoxicity in patients receiving systemic chemotherapy?
Population
86 patients with acute leukemia, malignant lymphoma, or multiple myeloma receiving systemic chemotherapy…
Design
Cohort
Authors
Loading...
Supports BNP monitoring in anthracycline recipients; leaves open whether it improves cardiotoxicity outcomes.
Does brain natriuretic peptide (BNP) level correlate with anthracycline-induced cardiotoxicity in patients receiving systemic chemotherapy?
Elevated BNP levels (≥100 pg/ml) during anthracycline chemotherapy correlate with the development of cardiotoxicity, suggesting its potential utility for monitoring.
Lee et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: